Abdelnour-Mallet M, 135
Abel O, 118
Abraham I, 25
Abrahams S, 32, 148, 162
Abrescia C, 117
Acevedo-Arozena A, 20
Adachi H, 83
Aebischer P, 52
Ahn S-W, 69
Ahtoniemi T, 70, 91
Aiso S, 22
Aizawa H, 108
Ajroud-Driss S, 111, 139
Akimoto C, 110
Alami N, 10
Al-Chalabi A, 29, 118, 154
Ali-Rahmani F, 79
Allcroft P, 17
Allen C, 21
Allen J, 139
Al-Nakhala B, 83
Al-Sarraj S, 104
Alvarez JL, 100
Alvisi E, 105, 115
Andersen PM, 29, 30, 49, 104, 106, 110, 112, 118
Andersson R, 110
Andjus P, 103
Ando H, 139, 140
Andres P, 23
Angus R, 139, 140
Ansorge O, 31, 99
Aoun S, 17
Appel S, 137
Archibald D, 36, 65, 141
Armes S, 169
Armon C, 120
Armstrong III E, 90, 117
Armstrong J, 139
Arnulf I, 126
Arts I, 23
Asayama S, 99
Atassi N, 49
Atkin J, 37, 89, 93, 99, 101
Avants B, 146
Ayala V, 54
Azzouz M, 169
Backus C, 71
Bahrke R, 41, 156
Bak TH, 32
Baker M, 114
Ball L, 153
Balma M, 17, 28, 56, 156
Banfi P, 129
Banno H, 83
Barbarini N, 106
Barber R, 171
Bareil C, 20
Barnham K, 68, 69
Barohn R, 154
Barrett E, 55
Barrett J, 55
Basta I, 155
Bastin M, 162
Bates S, 104
Battaglia G, 26, 169
Bäumer D, 31
Beart PM, 92
Bede P, 1, 131, 148, 157, 162
Bedlack R, 44
Beelen A, 127
Beghi E, 27
Bella P, 50
Belzil V, 114
Benatar M, 49
Bendotti C, 97
Benfenati F, 73
Bennett FC, 9
Berger J, 74, 75
Berman B, 43
Berna C, 147
Bernabei C, 121
Bersano E, 17, 144
Berwick J, 169
Bettinelli M, 50
Bhargava N, 38
Bianchi M, 105
Biba A, 31
Bica L, 68
Bigi R, 105
Bini L, 100
Birbaumer N, 24
Birve A, 110
Bizovicar N, 165
Black KJ, 18, 127, 128, 150, 151
Blair I, 116
Blasco H, 126
Blass B, 85
Blauw H, 29, 30
Blizzard CA, 87, 94
Blok J, 24
Blythe A, 150, 151
Boada J, 54
Bockenek WL, 128, 151
Boekestein W, 23
Boggio BD, 135
Boiocchi C, 115
Bokde A, 162
Bon J, 2, 164
Bonanno G, 73
Bonetto V, 97
Bongioanni P, 100, 117
Bonifacino T, 73
Bonino D, 117
Borisow N, 41, 156, 157
Bosco D, 30, 53
Bottacchi E, 28
Bouchard J-P, 114
Bowser R, 25, 102, 105
Boylan K, 33, 114, 119, 137
Bozik M, 36, 65, 141
Bradley D, 115
Brady S, 84
Brännström T, 104, 106
Bravver E, 18, 128, 150, 151, 152
Bremer B, 50
Brocard C, 39
Bromberg M, 56
Brooks BR, 18, 57, 80, 85, 90, 91, 117, 119, 128, 132, 140, 141, 150, 151, 152
Brothers A, 14, 146, 49
Brown RH Jr, 29, 30, 53, 107, 116
Brown R, 80
Brownlee A, 13
Brownstein C, 154
Bruening L, 13
Bruneteau G, 108, 135
Bucci EM, 117
Burke C, 53
Busta A, 21
Cacabelos D, 54
Caioli S, 94
Callagher P, 129
Calvo A, 17, 28, 56, 81, 135, 144, 156, 168
Cammarosano S, 17, 156
Campos Y, 100
Campous D, 103
Camu W, 114, 145
Canosa A, 17, 28, 144, 156
Canu N, 94
Caraballo-Miralles V, 54
Caragounis A, 90
Carrasco MA, 9
Carrion I, 82, 168
Carunchio I, 94
Casey P, 139
Cashman JR, 98
Cashman N, 52, 107
Cassel J, 85
Castelnuovo G, 129
Cazzolli P, 140, 141, 57
Cellotto N, 129, 50
Cereda C, 105, 106, 115, 98
Ceroni M, 105, 106, 115, 98
Cha J, 66
Chakrabarti B, 139, 140
Chalbi M, 135
Champion S, 101
Chan M, 65
Chang G, 88
Chatburn R, 57, 140
Chaverri D, 151
Chaves CA, 133
Chen G, 85
Chen H, 77
Chen R, 66
Chen X, 76
Chiang P, 167, 78
Chiheb D, 15
Chiò A, 17, 28, 56, 135, 144, 156
Chuah MI, 67
Chun S, 105
Chung R, 67
Clavelou P, 135
Clawson L, 138
Cleary S, 58
Cleveland DW, 9, 46
Cleveland M, 104
Coates J, 171
Coccia C, 92
Cohen SR, 12
Cohen-Fineburg I, 129
Coleman MP, 37
Collins M, 102
Colombrita C, 112
Colyer S, 17
Conceição E, 63, 133
Condon S, 120
Conforti L, 37
Connor J, 22, 54, 79, 109
Consoli P, 117
Conte A, 111, 153
Conway T, 78
Cooper L, 93
Corbo D, 161
Corbo M, 50, 97, 126, 129
Corcia P, 126
Corse A, 104
Cova E, 98, 105, 106, 115
Cox G, 74
Crawford J, 116
Creemers H, 127
Crook R, 114
Crouch P, 68, 69, 90
Cuccia M, 115
Cudkowicz M, 23, 36, 44, 49, 65, 105, 124, 141
Cui L, 76
Culvenor J, 68
Cunha M, 133
Cuppen E, 30
Currow D, 17
D’Ydewalle C, 15
Da Costa M, 21
Dahlberg C, 30
Dahodwala N, 136
Daoud H, 114
Das M, 38, 86
David G, 55
Davin A, 98
Davis H, 86
De Carvalho M, 1, 138, 166
De Jong SW, 27, 123, 124
De Visser M, 27, 30, 123, 124
Dedic V, 155, 158
Deitch J, 82
Dejesus-Hernandez M, 114
Del Grande A, 111, 153
Delanian S, 157
Deng M, 33, 85, 88
Dengler R, 132, 167
Desai U, 150, 151, 152
Desaro P, 114
Desjarlais A, 114
Desnuelle C, 135
Dewhurst E-K, 134
Dhand U, 171
Dhillon H, 68, 83
Di Maio G, 100
Di Stefano A, 100
Dick A, 154
Dickson D, 107
Dickson TC, 87, 94
Diekmann V, 24
Diekstra F, 30
Diez TE, 123
Dimachkie M, 154
Dion P, 114
Doi H, 83
Dolenc GL, 120
Donaghy C, 160
Donkervoort S, 111
Donnelly P, 68, 69
Doretti A, 112
Douaud G, 163
Dowling J, 21
Drenthen J, 24
Dreo J, 164
Drew A, 116
Droce A, 79
Drory V, 82
Duan W, 87, 88, 89
Dubourg O, 108
Duce J, 68
Duffy KS, 128, 151
Dullinger JS, 41, 156, 157
Dupré N, 114
Duran M, 133
Durand J, 39, 170
Durham H, 66, 93
Durnall J, 116
Duyckaerts C, 108
Ealing J, 143
Ebers G, 125
Edis R, 17
Edwards G, 171
Eggan K, 97
Elamin M, 148, 162
Elbasiouny S, 170
Elman L, 136, 146
Elmo M, 59, 136
Endo H, 110
England JD, 7
Ensrud E, 154
Ermans E, 74
Esposito F, 161
Esteban J, 100
Fadda M, 135
Fagan A, 162
Fajardo ML , 130
Fan D, 33, 85, 88 109, 165, 167
Fang D-F, 111, 164
Fanos J, 49
Farace E, 14
Farg M, 37, 89, 93, 101
Fathinia P, 159
Federico A, 100
Feldman E, 21, 71
Felgoise S, 18, 50, 126
Fernandes F, 81
Fernández E, 100
Ferraiuolo L, 46
Filipchuk A, 39
Filippini N, 25, 163
Filiz G, 90
Finch N, 114
Finocchiaro E, 135
Fischetti C, 120
Fisher EMC, 20
Fisher F, 144, 147
Flaherty-Craig C, 146
Fling B, 160
Focant M, 75
Forbes R, 160
Forsberg K, 104
Forshew DA, 7, 34, 101
Fossati F, 129
Foster S, 67
Fratta P, 20
Friedman BA, 9, 10
Frosali S, 100
Fu R, 38, 72, 169
Fujita K, 99
Fukuda M, 133
Fukumaki Y, 113
Fumoto K, 30, 84
Furlong CE, 30
Gagliardi A, 100
Gagliardi S, 98, 115
Gal J, 53
Galletti R, 135
Gallo S, 17, 28, 144, 156
Gamez J, 63, 113
Gandhi RB, 152
Ganesalingam J, 25
Ganzini L, 12
García A, 100
García-Chacón L, 55
García-Redondo A, 168
Gastl R, 159
Gdynia H-J, 159
Gellera C, 30, 116
Gély-Nargeot M-C, 145
Georgoulopoulou E, 121
Geser F, 107
Ghiroldi A, 106
Giacone S, 156
Gibbons C, 143
Gibson MJ, 160
Gill A, 68, 70, 83
Gilley J, 37
Giniatullin R, 70
Giniatullina R, 70
Giribaldi F, 73
Gitler AD, 52
Glass JD, 30, 116
Golaszewski A, 136
Goldoni CA, 121
Goldsteins G, 91
Gonzalez M, 86
Gordon P, 135
Gorelik R, 132
Gorni K, 129
Goursaud S, 74, 75
Grad L, 107, 52
Graff-Radford N, 114
Granado A, 54
Graves M, 119
Green M J, 14
Greenald D, 46
Greensmith L, 20
Gribkoff V, 36, 65, 141
Grissom J, 78
Groen E, 30, 84
Gronka S, 49
Grossman M, 146
Gruis K, 42, 160
Grupstra H, 127
Guareschi S, 98, 105, 106
Gueritaud JP, 39
Gullusci M, 117
Gunawardena D, 146
Guo X, 86
Guo X-Y, 111, 164
Guo Y, 73, 77, 87, 88, 89
Guy N, 135
Hadano S, 75, 96
Hanson K, 9
Hardiman O, 1, 29, 115, 131, 148, 157, 160, 162
Harmar A, 80
Harris R, 17, 41
Hartley R, 80
Hayward L, 53
Hazelett D, 77
He X, 110
He Z, 103
Healey M, 56
Heath P, 46
Heckman CJ, 38, 72, 169, 170
Hefferan M, 71
Heiman-Patterson T, 82
Heizmann C, 144
Heller S, 139
Hemendinger R, 80, 90
Henderson C, 52, 97
Hensler M, 68, 131
Hermans E, 75
Hernández M, 152
Heywood J, 44
Hickey J, 68
Hickman J, 38, 86
Hicks S, 147
Hideyama T, 108
Higginbottom A, 21, 46
Hill J, 134
Hilton D, 31
Hodges JR, 145
Hodskins J, 131
Hokonohara T, 113
Holm T, 41, 156, 157
Hong Y, 71
Honrada R, 101
Horne M, 37, 89, 93, 99, 101
Horton KD, 119
Hosie KA, 87, 94
Hoskins K, 136
Houseman G, 49
Hovatter R, 160
Hu M, 77
Hu X-H, 164
Huang E, 107
Huang J, 73
Huang R, 111, 164
Huelga S, 9
Huggins J, 42
Huisman MHB, 27, 123, 124
Hurtado F, 151, 152
Hutt KR, 9
Iber C, 57, 58
Ikeda J-E, 75, 96
Ikeda K, 75, 166
Ilardi A, 17
Ingersoll E, 36, 65, 141
Irobi J, 15
Ishikawa H, 96, 98
Ishikawa Y, 166
Ito H, 29, 99
Iwaki T, 113
Iwamoto K, 166
Iwasaki Y, 75, 166
Izumi Y, 29
Jack B, 13, 130
Jackson CE, 7, 154
Jackson V, 17
Jaffa M, 49, 105
Jaffer Z, 66
Jang J-W, 69
Janzen C, 41
Jaronen M, 91
Javaherian A, 26
Jelsone-Swain L, 160
Ji Y, 33
Jia H, 53
Jia J, 53
Jia Y, 87, 88
Jiang H, 88, 89
Jiang M, 169
Jin L, 47
Johe K, 71, 86
Johnston A, 114
Johnston WS, 7, 58
Jonsson A, 110
Jordan N, 148, 162
Joyce P, 20
Julien J-P, 20
Juntas-Morales R, 145
Kaji R, 29
Kalra S, 58, 7
Kamada M, 29
Kamitani T, 95
Kanazono S, 171
Kandinov B, 82
Kaneko S, 99
Kanekura K, 22
Kanekura M, 22
Kanninen K, 70
Kanning K, 52
Kaplan A, 52
Kaplan C, 59, 136
Karlsson PR, 79
Kasarskis EJ, 7, 44, 56, 131
Kassubek J, 24, 45, 159, 163
Katirji B, 59, 136, 137
Katsuno M, 83
Katz JS, 7, 34, 35, 64, 101, 137, 154
Kawabe K, 166
Kawakami H, 29
Kaye W, 119
Keagle P, 30, 116
Keegan L, 11
Kenna K, 115
Kennard C, 147
Kennelly K, 114
Kennerley A, 169
Khan A, 147
Kidd J, 68, 70, 83
Kihira T, 122
Kikuchi H, 113
Kim JM, 11
Kim K-E, 69
Kim SH, 9
Kimball R, 138
King AE, 87, 94
Kira J-I, 113
Kirby J, 46
Kissel J, 154
Kitamura E, 155
Klapper J, 49
Kleine B, 23
Klug R, 159
Knight S, 163
Knorr R, 120
Ko Hae K, 53
Kocerha J, 114
Kocher K, 82
Koistinaho J, 70, 91
Kokubo Y, 122
Kolarcik C, 102
Kollewe K, 132, 167
Kondo N, 83
Kondo T, 122
Kong J, 76
Korczyn A, 82
Koritnik B, 120, 165
Korogod S, 39
Kostic S, 155
Kraig S, 48
Krakow M, 43
Krampfl K, 132
Krishnan J, 15
Kristjanson L, 17
Kryscio R, 56
Kubalik N, 80, 91
Kulagina I, 39
Kunita R, 96
Kusaka H, 29, 99
Kushner G, 34
Kuzmanovic A, 158
Kuzuhara S, 122
Kwak S, 108
Kwiatkowski T, 53
Kwinter D, 53
Kwon O-S, 69
Lacomis D, 25, 105
Laforenza U, 98
Lafronza A, 34
Lagier-Tourenne C, 9
Lain AH, 108
Lam L, 68
Landers JE, 29, 30, 116
Landi C, 100
Langford V, 128, 151
Lanka V, 124
Lattante S, 111
Lau CL, 92
Lauranzano E, 97
Lavrnic D, 155, 158
Le Forestier N, 135
Lechtzin N, 137, 138
Leclerc AL, 30, 116
Lecorney A, 145
Lee G, 76
Lee S, 22, 79
Lee V M-Y, 7
Lee Y, 47
LeGuern E, 108
Lei P, 75
Leigh PN, 60, 104
Lemay N, 53
Lemmens R, 30
Lenglet T, 135
Leonardis L, 120
Lepore A, 48
Levi B, 14
Lewarski J, 57, 140
Lewis K, 67
Li C, 73, 77, 87, 88, 89
Li J, 39
Li Q-X, 68, 69, 90
Li W-Y, 72
Li X, 11
Li Y, 92
Li Z, 73, 77, 87, 89
Liabeuf S, 39
Liang TY, 9
Libon D, 146
Lillo P, 145
Lim N, 68
Lim S, 68, 69
Limousin N, 126
Lincecum J, 82, 168
Lindblom SS, 151
Ling S, 9
Linke P, 41, 156, 157
Liou L, 11
Lista S, 106
Liu H-N, 76
Liu Y, 22, 73, 87, 88, 109
Lladó J, 54
Loeb J, 78, 167
Lomen-Hoerth C, 107
Lorenzl S, 68, 131
Lowe J, 31
Lu J, 88, 89
Lu S, 22
Ludolph AC, 24, 29, 30, 45, 113, 144, 159, 163
Luigetti M, 111, 153
Lulé D, 24, 144
Lunetta C, 50, 97, 126, 129
Lunn S, 71
Lyter J, 49
Ma M-Y, 111
Ma Y, 89
Maathuis E, 24
Macías AI, 151, 152
Mackay C, 163
Mackenzie I, 107
Madia F, 111, 153
Madison C, 101
Madsen J, 169
Maestri E, 50
Magga J, 70
Magni P, 106
Maier A, 41, 156, 157
Mallet J, 108
Malm T, 70
Maloteaux J-M, 74, 75
Mancino MV, 135
Mancuso I, 111
Mandl RC, 160
Mandrioli J, 121
Maniatis T, 9, 97
Manzano R, 81, 168
Maragakis N, 48, 97, 137
Marangi G, 111
Marchiaro M, 117
Marconi A, 129
Maria Joaquina D, 63
Marín S, 130, 151, 152
Marklund SL, 104, 106, 110
Marsala M, 71
Martín R, 100
Maruyama H, 29
Mascías J, 151
Masel R, 82
Massagli M, 154
Masters C, 68, 69, 90
Mather J, 36, 65
Matsuda C, 141
Matsuo Y, 95
Matsuoka M, 22
Matte G, 161
Matthews D, 56
Mazur C, 9
Mazzini L, 28, 56
McCluskey L, 136, 146
McConigley R, 17
McDermott C, 21
McDermott MP, 35
McGivern CR, 160
McGoldrick P, 20
McGurk L, 11
McGrath MS, 101
McKenna-Yasek DM, 30, 53, 116
McKim D, 57, 140
McMillan C, 146
McVey A, 154
Mead R, 169
Meininger V, 44, 104, 108, 135
Meleo E, 153
Melisa A, 144
Mendaña L, 100
Mendiondo M, 56
Menke R, 25
Meola G, 50
Merino V, 100
Messa M, 73
Messina S, 34, 112
Meyer T, 29, 41, 45113, 156, 157
Meyerowitz J, 90
Mikami H, 96, 98
Milanese M, 73
Milani P, 105, 115
Milazi S, 85
Milde S, 37
Millecamps S, 108
Miller RG, 7, 34, 35, 36, 64, 101, 137
Miller T, 105
Milosevic M, 103
Minaya FJ, 151
Minamiyama M, 83
Mioshi E, 145
Misiaszek J, 58
Mitchell JD, 13, 129, 130, 143
Mitsumoto H, 7, 56, 65, 132
Miura S, 113
Mochizuki H, 155
Moglia C, 17, 56, 144, 156
Mohammadi B, 167
Molinari E, 129
Möller T, 11
Molnar P, 86
Monsurrò MR, 161
Montagnoli L, 117
Montarrás D, 81
Monteforte M, 97
Montuschi A, 144
Moore DH, 34, 35, 36, 64
Mora G, 28, 56, 97
Mora JS, 100, 130, 151, 152
Morales M, 113
Morán Y, 130, 152
Moreira G, 142
Morelli C, 34, 112
Moreno A, 68, 70
Morino H, 29
Morita M, 110, 112
Morrison B, 92
Morton D, 77
Moser JM, 79
Mougeot J-L, 85, 117
Moy P, 82
Mozaffar T, 154
Mueller H-P, 163
Müller H-P, 24
Münch C, 41
Muñoz JM, 81, 168
Muratet M, 9
Muravov O, 119
Musazzi L, 73
Mutani R, 28
Muzyka I, 154
Myers R, 9
Nagai M, 122
Nagley P, 101
Nakamura M, 99
Nakano I, 110
Nakayama Y, 141
Nandar W, 22, 54, 79
Nardo G, 97
Natale M, 117
Naudí A, 54
Neely B, 79
Neely E, 22, 54
Nefussy B, 82
Neumann M, 113
Neuwirth C, 110, 112
Newman D, 137
Nguyen K, 55
Nichelli P, 121
Nichols MS, 18, 128, 150, 151
Nicholson G, 116
Nilsson A-C, 110
Nishii M, 99
Nizet Y, 75
Nollet F, 127
Nomura M, 96, 98
O Brannagain D, 131
O’Banion C, 48
O’Brien D, 171
O’Brien M, 13, 130
O’Connell M, 11
O’Connor M, 17
O’Neil M, 128, 151
O’Neill M, 107
O’Shea RD, 92
Ogino M, 133, 155
Ogino Y, 155
Ogura A, 141
Ohyagi Y, 113
Okamoto K, 122
Oliván S, 81, 168
Oliveira A, 1, 133, 142
Oliver D, 131
Onders R, 59, 136, 137
Ono S, 96, 98
Ono S-I, 66
Onofri F, 73
Ophoff R, 29, 30
Oplinger H, 128
Oreja GC, 123
Ortiz-Padilla C, 79
Osta R, 81, 168
Otera A, 133
Otomo A, 75, 96
Overeem S, 23
Paccico T, 151
Paccone A, 161
Pacut C, 71
Pageot N, 145
Pagnini F, 126, 129
Paine S, 31
Palovcak M, 136
Pambo-Pambo A, 39
Pamplona R, 54
Pankratz N, 57, 58
Panov A, 91
Panzeri M, 50
Papadeas S, 48
Papurello D, 17
Parish C, 89
Park K-Y, 69
Parker S, 90
Paro S, 11
Pasnoor M, 154
Pasterkamp JR, 30, 84
Patel S, 57, 58
Pattee G, 153
Patterson B, 69
Patterson V, 160
Pauli F, 9
Pavlis A, 147
Pavlovic A, 158
Pawlyk A, 85
Pellizzoni L, 15
Pender N, 148
Perren F, 112
Perrin S, 82, 168
Petri S, 132, 167
Pettit L, 162
Phaneuf D, 20
Phatak V, 20
Phatnani HP, 9
Philip S, 21
Phukan J, 148
Piccirillo G, 161
Pieri M, 94
Piggin L, 140
Pignataro M, 97
Pillen S, 23
Pinnock R, 160
Pinto A, 138
Pinto S, 138, 166
Pioro E, 161
Platt S, 171
Podnar S, 164
Poletti B, 34
Poli A, 117
Pollari E, 70
Polymenidou M, 9
Ponfick M, 159
Ponsky J, 136
Popoli M, 73
Portero-Otín M, 54
Potter C, 56
Pouget J, 135
Powell J, 118
Pozzi S, 97
Pradat P-F, 104, 108, 135, 157
Pradella-Hallinan M, 142
Praline J, 126
Preston H, 129
Price A, 117, 85
Price K, 90
Puchalski R, 168
Qi X, 76
Quadros A, 1, 142
Queen E, 78
Quinlan K, 38
Rabe M, 113
Rabinowitz R, 82
Rademakers R, 114
Raju TR, 172
Ramesh T, 21
Ratti A, 112, 30
Ravina B, 35
Ravits J, 11
Raykar V, 134
Reardon K, 147
Reddy T, 9
Reed W, 83
Reiter-Theil S, 12
Reitz A, 85
Repovš G, 164
Ribchester R, 80
Ringer C, 81
Ristic KS, 120
Rivetti M, 135
Robberecht W, 15, 29, 30
Robertson J, 10, 76
Rodellar C, 81
Rodriguez de Rivera FJ, 123
Rodriguez-Leyva I, 30
Rosenberg A, 21
Rosenfeld J, 7, 42, 154
Rossi B, 100
Rossi G, 129
Rothstein J, 47, 92, 97, 104, 137
Rouleau G, 114
Roy-Bellina S, 145
Rubinstein A, 66
Rudnicki S, 141
Rumsey J, 38, 86
Rush B, 33
Russo P, 151, 152
Rutherford N, 114
Rutkove S, 39
Sabatelli M, 111, 153
Sabet D, 135
Sagnelli A, 161
Sakashita E, 110
Sakowski S, 21
Salachas F, 108, 135
Salas T, 130, 152
Saling S, 43
Sanchez M, 119
Sanchez R, 82, 168
Sanelli T, 10
Sanjak MS, 128, 151, 152
Sansone V, 50
Sanz Gallego I, 123
Sapp PC, 30, 53, 116
Sarma T, 84
Sasaki S, 104
Sawada J, 108
Schelhaas HJ, 23, 27, 30, 123, 124
Schengrund C-L, 79
Schilz R, 59, 136
Schmalbach S, 132
Schmalix W, 68
Schmitt-John T, 79
Schoenfeld D, 36
Schuster J, 38, 72, 169
Schütz B, 81
Scotto M, 138
Seidler R, 160
Seilhean D, 108
Sellitti L, 56
Sepulveda L, 119
Shang H-F, 76, 111, 164
Shapiro B, 107
Sharma R, 147
Sharp P, 169
Shaw CA, 76
Shaw CE, 25
Shaw G, 25
Shaw P, 46, 143, 169
Sheean R, 92
Shefner J, 36, 44
Sher R, 74
Sherman A, 65, 124
Sherratt N, 68
Sheward J, 80
Shimizu T, 141
Shin H-W, 69
Shoesmith C, 7
Siddique N, 111, 49
Siddique T, 38, 111, 139, 169
Sieniawski M, 132
Silani V, 30, 34, 112, 116
Silva T, 63, 133, 142
Simmons Z, 14, 18, 22, 49, 50, 54, 56, 79, 109, 126, 146
Simpson E, 137
Sinani E, 65
Singleton E, 42
Sinzenich T, 167
Skerry L, 23
Slowik A, 29
Smith R, 10
So Y, 137
Sobue G, 83
Sola P, 121
Solca F, 34
Solski J, 116
Song F, 78, 167
Song X, 88
Soo K Y, 89, 93, 101
Soon C, 68, 69, 90
Sorg S, 144
Soriani M-H, 135
Soundarararjan P, 74
Spano G, 97
Sperfeld A-D, 159, 163
Spiller K, 52
Spitalny M, 34
St. Clair W, 131
Stancescu M, 38, 86
Stanislaw C, 49
Stephens HE, 18, 50
Stevic Z, 103, 155, 158
Stewart J, 77
Stipa G, 111
Stojanovic Rakocevic V, 155
St-Onge J, 114
Strober J, 107
Strong MJ, 7, 103
Strulovici B, 26
Stukovnik V, 120, 164
Stutzki R, 12
Sufit R, 139
Sutedja N, 123, 124
Suzuki H, 22
Suzuki K, 83
Suzuki M, 96, 98
Svoboda R, 146
Swarup V, 20
Swash M, 125, 138, 166
Syriani E, 113
Takahashi K, 133
Talbot K, 25, 31, 99, 143, 147, 154, 163
Tan J-L, 68
Tanaka F, 83
Tandan R, 56
Tardito D, 73
Taroni F, 30
Tateishi T, 113
Taverna R, 144
Taylor B, 43
Taylor E, 134
Taylor PJ, 10
Tedeschi G, 161
Tennant A, 143
Thoeng A, 116
Thomas V, 116
Thompson K, 68, 70, 83
Thomson D, 80
Thornton C, 15
Thornton E, 139, 140, 143
Tibbetts R, 9
Ticozzi N, 30, 34, 112, 116
Tierbach J, 112
Tiloca C, 112
Timmerman V, 15
Tiryaki E, 57, 58
Toivonen J, 81
Tokuda E, 66
Tomik B, 29
Tonali PA, 111, 153
Toronjo M, 154
Torre-Merino P, 168
Torri V, 97
Towne C, 52
Tradewell M, 66, 93
Trojanowski J, 107
Trojsi F, 161
Tsingalia A, 92
Tufik S, 142
Turner B, 37, 68, 89, 93, 99
Turner M, 25, 31, 125, 147, 154, 163
Uckingham M, 81
Umbertina R, 63
Unrath A, 163
Urano F, 22
Usuki S, 95
Valan M, 34
Valera HF, 151, 152
Van Blitterswijk M, 30
Van Damme P, 15, 30
Van Den Berg LH, 27, 29, 30, 84, 123, 124, 127, 160
Van Den Berghe P, 15
Van Den Bosch L, 15
Van Den Heuvel MP, 160
Van Der Hulst E-J, 32
Van Der Kooi AJ, 27, 30, 123, 124
Van Doormaal PTC, 27
Van Doorn P, 24
Van Es M, 29, 30
Van Vught P, 29, 30
Vasquez L, 171
Veldink JH, 27, 29, 30, 123, 124, 127, 160
Verschueren A, 135
Verstraete E, 160
Vickers JC, 87, 94
Vieira F, 68, 70, 83, 168
Villamil AJ, 171
Vinci E, 117
Visser G, 24
Waibel S, 29, 113
Walgren K, 128, 151
Walker A, 37, 89, 93, 101
Walker M, 49
Wallace K, 124
Walsh S, 18, 49, 50
Wan Q, 109
Wancewicz E, 9
Wang J, 85, 88
Wang K, 33
Wang L, 39, 169
Wang M, 82, 168
Wang Q, 73, 77
Wang Y-H, 72, 154
Ward AL, 128, 132, 151
Warraich S, 116
Watanabe T, 96, 98
Weber M, 12, 110, 112
Wei L, 33
Weihe E, 81
Weinreich S, 27
Wells S, 56
Welsh R, 160
West A, 67
Wheeler S, 58
White A, 68, 69, 90
Whitehead B, 13, 130
Wicks P, 44, 154
Wiener C, 138
Williams C, 140
Williams K, 116
Williams NM, 18, 127, 128, 150, 151
Wills A-M, 30
Winer L, 105
Wojtas A, 114
Wolfe L, 139
Woolley SC, 7, 33, 34
Wren P, 42
Wright KA, 128, 150, 151
Wszolek Z, 114
Wurster U, 167
Wurthner J, 104
Wuu J, 49
Xiao S, 10
Xie Y-M, 72
Xu Y, 110, 165
Yamano T, 96, 98
Yamashita T, 108
Yanai A, 52
Yang Y, 111, 47
Yao X, 110
Yap YC, 87
Yasui K, 96, 98
Yates P, 17
Yeo GW, 9
Yoshida S, 122
Yoshii Y, 75, 166
Youn Y-C, 69
Young C, 139, 140, 143
Young J, 18
Yu H, 65
Yu J, 87
Yu RK, 95
Yu X, 88, 89
Zaragoza P, 81, 168
Zeng Y, 111, 164
Zetterström P, 106
Zgonc V, 120
Zhai J, 53
Zhang B, 78
Zhang C, 72
Zhang J, 53, 107, 165
Zhang K, 73, 77
Zhang R, 101
Zhang S, 165
Zhang Y, 85, 88, 167
Zhao B, 111
Zhao C-P, 72
Zhao X-S, 154
Zheng J, 165
Zheng M, 109
Zhou C, 72
Zhou D, 111
Zhou H, 53
Zhu H, 53
Zidar I, 120, 165
Zidar J, 120, 164, 165
Zinkie S, 66
Zinman L, 10
Zollino M, 111
Zona C, 94
Zwarts M, 23
Zwiegers P, 76
Subject Index
AAC, 13
AAC-compliance, 42
access, 41
activities of daily living, 133
activity, 80, 83
acylated steryl glucoside, 95
adaptive equipment, 132
ADAR2, 108
adherence, 139
adult motoneuron, 38
advanced care planning, 14, 129
advocacy, 44
aggregates, 93
airway clearance, 58
alcohol, 124
ALDH1L1, 47
alexithymia, 145
alpha-synuclein, 95
algorithm, 168
ALS team communication, 128
ALS2, 96
ALSFRS-R, 35, 36, 50, 65
ALS-PDC, 76, 95
altered mental status, 128
alternative splicing, 77
amino acids, 98
AMPA receptor, 108
androgen receptor, 83
angiogenin, 30, 110
angiogenin P (-4)Q, 110
angiogenin V105A, 110
animal model, 172
anosognosia, 146
antibodies, 107
antisense oligonucleotides, 105
apathy, 144, 145
apoptosis, 100
assessment, 12, 50
assistive
devices, 133
technology, 42, 132
association, 30
astrocytes, 46, 73, 75, 92
astroglia, 47, 97
Ataxin-2, 52
attitudes, 136
audit, 127
autolysosome, 104
automation, 83
autonomic impairment, 82
autophagosome, 96, 104
autophagy, 11, 69, 104
axon
degeneration, 87
pathology, 94
axonal transport, 37
basophilic inclusions, 31, 113
behaviour, 144
behavioural changes, 145
bioinformatics, 117, 118
biology, 60
biomarker, 25, 163, 167, 168
bionanotechnology, 26
BMI, 155
brain, 91
bulbar, 153
bulbar
involvement, 165
onset, 153
bursts, 169
Ca2+ homeostasis, 103
calcium, 93, 122
candidate, 115
canine, 171
caregiver
assessment, 49
needs, 49
caregivers, 129
care-giving, 50, 144
carer burden, 145
carer, 12
case
control, 17
management, 128
caspase, 75
cell
autonomy, 48
biology, 77
death mechanisms, 90
cellular therapy, 63
cerebrospinal fluid, 25, 102, 106, 172
CGRP, 81
Charcot-Marie-Tooth disease, 15
cholecystitis, 155
cholesterol, 79
classification, 148
clinical
assessment, 151, 152
evaluation, 153
progression, 64
trial, 36, 44, 64, 65, 124, 138
conduct, 44
design, 35, 64
CLIP, 10
CMAP scan, 24
CNV, 29
cognition, 34, 144, 147, 162, 164
cognitive, 147, 148, 162
cognitive
change, 32
functioning, 144
impairment, 33, 146
screen, 33
cognitive/behaviour
impairment, 148
communication device, 132
communication, 13
co-morbid conditions, 124
compliance, 44
computer-based decision aid, 14
computerized tools, 34
consensus criteria, 148
copy number, 82
corpus callosum, 163
cortical neurons, 94
cortical thickness, 160
cross-cultural comparison, 126
CSF, 105
CuII(atsm), 68
culture model, 66
culture, 81
cycloergometer, 50
cytokines, 115
data management, 65
database, 118, 119, 120
de novo, 114
death certification, 121
decision-making, 136
deep vein thrombosis, 156
default-mode network (DMN), 161
degeneration, 7, 80
degenerative myelopathy, 171
delivery system, 26
depression, 143, 144
development, 39
dexpramipexole, 36, 65
diagnosis, 23, 166
diagnosis/prognosis, 97
diagnostic
journey, 13
validity, 33
diaphragm function, 59
diaphragm pacing, 59, 136, 137
diffusion tensor imaging (DTI), 24, 25, 160, 163
dimebolin, 68
disease
mechanisms, 93
progression, 23, 120, 161
specific certification, 151
disulfide bond 76
dosimetry, 157
Drosophila, 11, 77, 78
duplex sonography, 156
dying back, 37
dynein, 37
dysarthria, 153
dysfunction, 162
dyspnea, 141
early phase, 33
EDC, 65
education, 17
efficacy data for NIV, 139
EGCG, 87
electromyography, 164, 165, 166
electrophysiology, 38, 94, 170
eliminating rate, 167
embodied cognition, 32
embryonic stem cells, 74, 85
emergency
hospitalizations, 57
services, 134
end of life care, 12, 17
end-of-life, 13, 14, 129
energy expenditure, 56
enrichment, 85
enrolment, 44
ensheathing cells, 63
epidemiology, 27, 120, 121, 122
ER stress, 22, 37, 89, 93, 101
ER-Golgi, 37
estrogens, 123
euthanasia, 12
evaluation, 17
event related potentials, 164
evolution, 123
excitability, 72
excitotoxicity, 44, 54, 87, 88, 94, 103, 170
executive function, 146
exercise, 145
exocytosis, 73
exome sequencing, 116
exon array, 77
extracellular matrix, 102
eye-tracking, 147
falls, 134
familial ALS, 49, 111
family carers, 130
fast axonal transport, 84
fatigue, 142, 143
fcMRI, 160
ferritin, 166
financial cost, 130
fluoxetine, 72
flutamide, 84
fMRI, 24
frontal functions, 34
frontotemporal, 147
frontotemporal
dementia, 49, 162
lobar degeneration, 146
functional
status, 143
tests, 165
FUS/TLS, 9, 31, 53, 84, 107, 108, 113, 114
ganglioside antibodies, 167
gastrostomy, 136
GCLC, 73
G-CSF, 70
gender, 122
gene, 116
gene
expression, 77
identification, 116
networks, 117
profiling, 52
genetics, 30, 112, 113
genetic
background, 74
counselling, 49
testing, 49
genome wide study, 118
genome-wide association study, 29
GFAP, 75
glia, 9, 48, 94
glial
activation, 78
cells, 104
cytoplasmic inclusion, 113
glucose, 100
glutamate, 75, 92
glutamate
excitotoxicity, 87
injury, 109
release, 73
transporter 1, 74
GSEA, 117
GSK-3 inhibitor, 69
guidelines, 7
handedness, 154
hazard ratio predictive value, 138
HFE, 22, 79, 109
HFE
gene, 110
H63D, 54
high-resolution EEG, 164
high-throughput
screen, 85
sequencing, 9
Hirayama disease, 157, 164
historical controls, 64
history, 125
HO-1, 88, 89
Hodgkin, 157
home
care, 128
parenteral nutrition, 135
hospice care, 140
hSOD1G93A, 74, 88
Hsp90 inhibitor, 66
human mesenchymal stem cells, 72
human, 86
hydrotherapy, 133
hyperlipidemia, 155
hyper-metabolism, 100
hypoventilation, 58
IGF-I, 71
IgG, 103
imaging, 162
immobilisation, 156
immunohistochemistry, 81
immunomodulation, 70
impairment-quantification, 151, 152
impedance, 39
in vitro, 38, 86
incidence, 27, 28, 121, 122
incident, 148
inclusion body myositis, 108
indirect calorimetry, 135
inflammation, 70
inflammation/activation
markers, 101
inherited ALS, 49
in-home services, 128
injury, 134
insight, 146
internet web patient portal, 18
interneurons, 169
interstitial space, 106
interventions, 50
intramuscular injection, 67
intronic mutation, 110
iPSC, 26, 97
iron, 54, 109
ISH, 168
juvenile ALS, 31
key worker, 41
Kii-ALS, 122
lactate stress test, 167
language, 32
laser capture microdissection, 11
lateral corticospinal tract, 167
lifestyle factors, 122
linear mixed effects model, 35
linkage, 116
lipid rafts, 79
lipids, 166
longitudinal, 34
longitudinal study, 129
lower extremity amyotrophic diplegia, 154
LST-decisions, 144
lymphocytes, 100
macrophage, 82
malnutrition, 135
mass spectrometry, 25, 102
mechanical ventilation, 155
mechanism of action, 69
medical emergency, 134
metabolism, 47, 92
metallothionein, 66, 67
metals, 90
methodology, 148
microarray, 46, 78, 117
microRNA, 11
misfolded SOD1, 106
mitochondria, 55, 80, 93
mitochondrial
abnormalities, 104
apoptosis, 101
respiratory chain, 100
transmembrane potential
(MTP), 100
modeling, 39, 170
modifier, 74
monitoring, 166
monocyte/macrophage
activation, 101
monomelic amyotrophy, 157
morphology, 39
mortality, 121
motor
acquisition, 63
behaviour, 172
cortex, 160
nerve terminal, 55
neuron biology, 11
neuron degeneration, 79
neurons, 9, 46, 85, 87, 97
mouse models, 15, 20
movement related cortical potential, 165
MRI, 157, 162, 164, 169
mRNA, 98
multidisciplinary care, 18, 134
MUNE, 39, 171
muscle, 81
muscle
atrophy, 168
biopsy, 168
pathology, 104
mutation, 20, 30, 107, 111, 114
myofibrillary architecture, 104
nanoparticles, 169
national databases, 119
natural voice, 42
needs assessment, 127
neuregulin, 78, 167
neurodegeneration, 78, 80
neurofilament, 103
neuroimaging, 161
neurology clinical trials unit, 65
neuromuscular junction (NMJ), 38, 80, 86, 87
neuronal viability, 22
neurons, 7, 26
neuropathology, 102, 125
neurophysiology, 24
neuroprotection, 21
neuropsychological
assessment, 34
neuropsychology, 32
neurotransmitters, 171
next-generation sequencing, 116
NFkB, 29
nicotinamide, 85
NIPPV, 137
NIV, 56, 57, 137, 138, 139, 140, 141
NIV titration, 57
noncompliance, 139
noninvasive positive pressure ventilation, 140
non-neuronal cell, 66
Nrf2, 88, 89
NSC-34 cells, 84, 90
nuclear localization sequence (NLS), 53
nucleus, 104, 105
nursing
care, 43
role for NIV, 139
nutrition, 56
occupational therapy, 133
ocular fixation, 160
oculomotor, 52
oligodendroglia, 47
‘omics’, 60
onset, 154
optical imaging, 169
optineurin, 29
oral secretions scale, 141
oral secretions, 140
orthopnea, 141
outcome, 28, 56
outcome
measures, 23, 150, 152
registry, 119
out of hours, 134
outpatient care, 41
oxidation, 76, 106
oxidative damage, 54
oxidative stress, 21, 88, 90, 105
p.R521C, 113
pain, 17
palliative
care, 17, 41, 131
care education, 17
paraoxonase, 30
parkinsonism-dementia
complex (PDC), 96
parotid, 131
pathoanatomy, 163
pathology, 82, 107
pathway, 115
patient
management, 7
outcomes, 151
PEG, 136
percutaneous endoscopic gastrostomy tube, 136
performance measures, 150, 151
peripheral
blood mononuclear cells, 97
neuropathy, 15
permeability transition pore, 55
personal experiences, 13
pharmaceuticals, 26
pharmacology, 92
phase II trial, 35
phenotype, 20, 28, 60, 112, 153, 161, 167
phosphorylated
Smad2/3, 99
TDP-43, 54
phrenic
nerve, 137
nerve motor response, 138
physical activity, 50, 123
physician/patient communication, 17
pilot projects, 119
pioneers, 125
PMA, 154
polymorphisms, 115
polysomnography, 57, 58
population-based study, 56
population-based, 17, 27, 123, 124
postnatal development, 38
post-polio syndrome, 142
practice parameters, 7
predictive equations, 56
Preferred Priorities for Care, 129
prefrontal
dysfunction, 32
lobar dysfunction, 33
prevalence, 120, 121, 124
primary endpoint, 35
primitive reflexes, 147
prion-like activity, 52
prognosis, 25, 153
progression, 24, 167
prospective memory, 33
protein
aggregation, 102
biomarkers, 97
disulfide isomerase, 91
misfolding, 52, 93, 107
-protein interaction, 84
proteomics, 10
PSP, 160
psychological assessment, 126
PTEN, 109
qualitative
analysis, 143
research, 13, 130
quality improvement, 128
quality of life, 12, 18, 126, 128, 129, 132, 143
quantitative
sensory testing, 159
strength measures, 23
Rab5, 96
radiation, 131
radiologic inserted
gastrostomy, 135
radiotherapy, 157
rapamycin, 69, 70, 94
rare variant, 29
rare variation, 30
rat, 39
reactive astrocyte, 47
recruitment, 44
redistribution, 89
registry, 119, 120
rehabilitation, 42, 58
relationships, 43
reliability, 141
religiosity, 12
remote evaluations, 49
research question, 35
resistance, 52
respiration, 58, 165
respiratory failure, 57, 59, 137
resting
energy expenditure, 135
state, 160
resting-state functional
magnetic resonance imaging (RS-fMRI), 160, 161
restless legs syndrome, 126
resveratrol, 85, 88
retention, 44
riluzole, 88
risk factors, 27
risk, 123
RNA, 10, 103
RNA
binding proteins, 52
editing, 11
metabolism, 10
processing, 9
splicing, 15
transcriptiome, 47
root recording, 169
ROS, 91
saccades, 160
safety, 135
sample size, 35
satellite cells, 81
SBMA, 83, 84
Schwann cells, 82
screening, 34
SELDI-TOF-MS, 106
self-management, 41
sensory system, 24
sequencing, 115
serotonin, 72
sexual expression, 43
sexuality, 43
sialorrhea, 131
single nucleotide polymorphism, 110
Sirt1, 85
sit to stand test, 152
skin, 96
sleep disturbance, 126
sleep, 57, 142
SMA, 15, 99
SMA type I, 63
Smad ubiquitination
regulatory factor-2, 99
small-fibre neuropathy, 159
smoking, 124
social
cognition, 32
problem solving skills, 18
social-care, 130
SOD1, 20, 21, 52, 75, 78, 80, 82, 91, 98, 101, 104, 105, 106, 107, 110, 111
SOD1
aggregation, 76
conformation, 76
G93A mouse, 67, 68, 70
mouse, 38
mutation, 111
transgenic mice, 82
-G93A, 68, 70, 83, 168
-G93A mice, 67, 68, 70, 72, 73
-G93A/HFE+/H67D, 54
I113T, 111
software, 119, 131
somatosensory nerve system, 159
Spain, 130
speech therapy, 132
spinal
cord, 98
cord heart mitochondria, 91
spirituality, 12
splice
variant, 110
variants, 74
sporadic ALS, 99
spread, 154
stair climbing test, 152
STARD, 23
stem cells, 48, 63, 71
stigmasterol β-D-glucoside, 76
stress
granules, 53
response, 66
structural MRI, 146
study biological markers, 45
substantia nigra, 158, 159
suicide, 12
sulforaphane, 88
support, 130
survey, 42
survival motor neuron, 15, 99
survival, 120, 155
swallowing, 58
Switzerland, 112
sympathetic activity, 82
symptom control, 131
symptomatic
management, 131
therapy, 159
synthetic technology, 26
Talampanel, 44
TAR DNA, 85
TARDBP gene, 111
TARDBP, 112, 113
TARDP mutations, 112
TDP-43, 7, 9 10, 20, 52, 68, 77, 85, 89, 90, 108, 109, 112
technology, 43
telemedicine, 49
tele-nursing, 18
telephone advice, 18
terminal illness, 12
TGF-beta, 83, 99
The Joint Commission, 150
therapeutic, 69, 71
therapy, 64, 68
Tie-2, 101
timed-tests, 151, 152
transcranial sonography, 159
transcranial, 158
transcription factor, 69
transgenic mice, 66, 73
transplantation, 72
transporters, 75, 92
transthyretin, 102
trapezius, 165
treatment acceptability, 140
ubiquitination, 117
ultrasonography, 23, 158
ultrastructural studies, 96
unfolded protein response, 22
university palliative care unit, 131
uPA inhibitor WX-340, 68
uPA, 68
urate, 166
valproic acid, 63
VAPB, 22
VEGF inhibitor, 156
ventilation, 138
vesicle traffic, 79
vital capacity, 141
voice-banking, 42
voxel-based morphometry, 161
VSC4.1 cell line, 88
vulnerability, 81
walk, 133
Wallerian degeneration, 37
web-based self-assessment, 41
wobbler mouse model, 79
zebrafish, 21, 53